Hereditary ataxias are a heterogeneous group of progressive neurodegenerative disorders characterized by symptoms and signs originating mainly in the CNS. A new representative of this disease group is infantile onset spinocerebellar ataxia, an autosomal recessively inherited syndrome so far reported only in the genetically isolated Finnish population. The etiology of hereditary ataxias still remains unknown, but the gene loci behind many of them have been mapped to different chromosomal regions. We have carried out linkage analyses with markers on the regions of the previously identified ataxia loci to determine whether the infantile onset spinocerebellar ataxia syndrome represents the same allelic disease as any of the previously identified hereditary ataxias. Here we report that the infantile onset spinocerebellar ataxia syndrome does not segregate with any of the markers closely linked to the other hereditary ataxias. Consequently, it represents a genetically distinct disease, the gene locus of which still has to be identified. Hereditary ataxias are a heterogenous group of progressive neurodegenerative disorders characterized by cerebellar symptoms, combined with features including peripheral neuropathy, ophthalmoplegia, optic atrophy, retinal de: generation, deafness, endocrinologic symptoms, and cardiomyopathy. Some of the diseases, e.g. FA, are clinically and genetically well defined, but the etiology of the majority of them is unknown. Classification of the different syndromes is based on the clinical symptoms, the age of onset, and the pattern of inheritance (1).
We have recently described a new form of hereditary ataxia, IOSCA (2, 3) . The clinical symptoms in this syndrome include cerebellar ataxia associated with peripheral sensory neuropathy, cerebral symptoms including athetosis and epilepsy, deafness, ophthalmoplegia, optic atrophy, and, in females, primary hypogonadism. We have identified 19 patients with this recessively in-
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herited disease in the genetically isolated population of Finland.
Most ataxia syndromes are hereditary, and both autosoma1 dominant and autosomal recessive inheritance have been reported. Because the basic biochemical abnormality is unknown in these diseases, a random search of the human genome would be a relevant approach to revealing the defective gene loci. The random mapping procedure uses highly polymorphic and multiallelic DNA markers that have been assigned to certain chromosomal regions. The data of the inheritance of the disease in the families is compared with the inheritance pattern of the marker alleles in the same families. The probabilities for the disease and the marker loci being closely located, i-e. linked, are calculated using the LINKAGE package of computer programs (Jurg Ott, Columbia University, New York). Indeed, the loci for several hereditary ataxias have been successfully assigned by means of random linkage analyses.
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to the long arm (q) of chromosome 9 (4-6). The gene locus of a similar kind of ataxia resulting from selective vitamin E deficiency (AVED) has been localized to the proximal part of chromosome 8q (7) . AT is an autosomal recessive disease manifesting itself in childhood, and the corresponding gene maps to the chromosomal region 11q22-q23 (8) . Autosomal dominant SCAl and SCA2 are also assigned to different genetic loci: the genes for SCAl and SCA2 have been mapped to chromosomal regions 6p23-p24 (9, 10) and 12q23-q24.1 (1 I), respectively. In addition, some types of FSP bear a close resemblance to the hereditary ataxias. Autosomal dominant FSP has been shown to be genetically heterogenous, but one locus has been mapped to chromosome 14q (12) .
The aim of this study was to determine whether the Finnish form of hereditary ataxia, IOSCA, represents the same allelic disease as any of the previously known hereditary ataxias. We used IOSCA family material to perform linkage analyses to the microsatellite markers flanking the known ataxia loci.
METHODS
All the 13 known Finnish IOSCA families, with 42 healthy and 19 affected family members, were included in this study. Informed consent was obtained from all the families. Six families had two affected children, the rest only one affected child. The patients were diagnosed at the Children's Hospital of the University of Helsinki. The diagnosis was based on the following clinical symptoms: acute or subacute appearance of ataxia, athetosis, and the loss of deep tendon reflexes in a child with normal development until the age of 9 to 18 mo as well as deafness, ophthalmoplegia, optic atrophy, and sensory neuropathy, which subsequently developed during childhood years (2, 3) .
DNA analysis. Ten mL of peripheral venous blood was obtained from all the individuals, and genomic DNA was extracted from the leukocytes by standard procedures (13) . A total of 28 highly polymorphic amplifiable microsatellite markers were analyzed. The PCR (14) primers used to amplify the marker sequences originated either from the Genethon (Eury, France) amplifiable marker collection (The Genethon Microsatellite Map Catalogue, 1992) or the marker collection of the Nordic Human Genome Organization collaboration project. The order of the markers and the genetic distances between them were based on published genetic maps (15) (16) (17) . One of the primers was 5' end-labeled with 3 2~-y~~~ (Arnersham, Little Chalfont, UK) using T4-polynucleotidekinase (Pharmacia, Piscataway, NJ) in its buffer at 37°C for 30 min. PCR was performed in a volume of 15 FL containing 12 ng of template DNA, 3 pmol of primers, 0.2 FM each of the nucleotides, 20 mM Tris-HC1 (pH 8.8), 15 mM (NH4),S04, 1.5 mM MgCl,, 0.1% Tween 20, 0.01% gelatin, and 0.25 U Thermus aquaticus DNA polymerase (Promega, Madison, WI). The PCR conditions in multiwell microtitration plates were as follows: denaturation at 92°C for 30 s, annealing at 48-64°C (depending on primers) for 30 s, and extension at 72°C for 30 s for 28 cycles. In the first cycle, however, denaturation lasted for 3 min, and extension in the last cycle was 5 min. The amplified fragments were separated by electrophoresis (1400 V, 4 h) in 5% denaturing polyacrylamide sequencing gels. The gels were dried and subjected to autoradiography on Kodak X-omat film for 2-48 h. The different alleles of the polymorphic markers were determined from the autoradiographs.
Computer analysis. To find out whether any conclusive results could be drawn from linkage analysis of the available family material, we first carried out data simulation analysis assuming a single marker locus and double heterozygosity in the parents. We used the MSIM option of the SLINK program with 500 replicates (one replicate equals one round of generating marker genotype for each individual) to obtain the elod (expected logarithm of the odds score) values (18, 19) .
We compared the inheritance pattern of the different alleles of the polymorphic markers with the inheritance of the disease in the families. To calculate the likelihood, expressed as a painvise lod score, of the possibility that the disease and the marker loci are located close to each other, we used the MLINK option of the LINKAGE package programs (version 5.10), assuming an autosomal recessive pattern of inheritance for the IOSCA gene with an estimated frequency of loe3 in the Finnish population and equal recombination rates for the males and females (20) . Because of the early onset of the disease, complete penetrance was assigned. The disease is enriched in the genetically isolated Finnish population; the possibility of locus heterogeneity can be considered highly unlikely and locus homogeneity was assumed. The allele frequencies for each marker were assumed to be equal, because DNA samples were available from most subjects. Multipoint analyses combining the information from the markers on the same chromosomal region were carried out with the LINKMAP program of the LINKAGE package.
RESULTS
We analyzed markers on the six different chromosomal regions flanking the gene loci reported to be associated with hereditary ataxias in all 13 Finnish IOSCA families identified and diagnosed in this population (Fig. 1) . The family material included only six families with two affected children, the rest of them having only one diseased child. Consanguinity was identified in two of the families; the parents of one family were first cousins, and the father of one patient was a second cousin of another patient. Fourteen of the 19 patients originated from North Carelia, a county in the eastern part of Finland (Fig. 2) . Although the majority of the ancestors originated from eastern Finland, many of their birthplaces are scattered throughout the country. This suggests that the IOSCA mutation is quite old. However, the clustering of the a recombination fraction of 0.05. According to this simulation analysis, an evenly spread set of informative markers should result in a conclusive lod score in our limited family material. Table 1 summarizes the two-point lod scores between the IOSCA syndrome and the markers linked to the loci of the other hereditary ataxias. None of the markers analyzed showed evidence of linkage with the IOSCA gene. The degree of exclusion produced by the different markers varied according to the informativeness of the markers within the families.
The FA gene has been assigned to chromosome 9q13-q21, and strong evidence for linkage was found with marker D9S15 (4-6). By analyzing six polymorphic markers, D9S43, flanking the FA locus on chromosome 9. In multipoint linkage analyses, the lod scores remained highly negative (< -3)
ancestors in eastern Finland suggests that there is one major mutation behind the syndrome in this population. Simulation analyses assuming full penetrance and locus homogeneity in this family material revealed a mean elod of 2.979 with a standard deviation of 1.036. The maximum lod score was 4.820, and at a recombination fraction of 0.01 the expected lod scores ranged from 1.943 to 4.014 (90% confidence interval). The lod score still remained significant in more than 30% of the replicates at throughout the area spanning from D9S43 to D9S176. This excluded the possibility that the chromosomal region containing the FA gene might also cover the IOSCA gene.
The gene for the AVED syndrome maps to chromosome 8q21 (7) and is tightly linked to the D8S260 marker. Multipoint linkage analyses combining the information from markers D8S285, D8S260, and D8S279 also resulted in negative lod scores and demonstrated that the IOSCA The gene locus of the AT syndrome on the chromosomal region 11q22-q23 (8) could be excluded after analysis of the polymorphic markers DllS3.5, DRD2, CD3D, and DllS925. The strongly negative lod scores (<-5) obtained in the multipoint map combining the information from these markers on the long arm of chromosome 11 showed that the genetic backgrounds of the IOSCA and AT syndromes are not the same.
In analysis of the gene region for the SCAl syndrome on chromosome 6p22-p23 (9, lo), the results of multipoint linkage analyses with markers D6S309, D6S259, D6S285, and TNFB excluded a contiguous area of more than 20 cM extending on both sides of the SCAl locus as a site for the IOSCA gene. Analogously, linkage analyses of markers D12S82, D12S78, D12S86, and D12S76 excluded a continuous area of nearly 50 cM on distal 12q as the IOSCA locus, the exclusion flanking the SCA2 locus on 12q23-q24.1 (1 1). Finally, multipoint linkage analysis of markers D14S80, D14S75, D14S269, D14S66, D14S63, D14S43, and D14S74 demonstrated that the IOSCA gene is not located on the region of 70 cM covered by these markers and thus does not represent the same allelic locus as the FSP syndrome type assigned to this chromosomal region (12) (Fig. 3) .
DISCUSSION
The Finnish population has remained genetically isolated throughout the ages for linguistic and geographical reasons. This isolation has led to the enrichment of some 30 hereditary diseases, known as the Finnish disease heritage. Such a genetically isolated population is ideal for genetic research; it creates a unique opportunity to identify the defective gene loci of otherwise rare diseases enriched in this population. In addition, enriched diseases are frequently caused by one ancient mutation, which makes the assignment of disease loci easier, as in the efficient application of linkage disequilibrium in mapping strategies. Indeed, the Finnish population has been successfully used in the mapping of the genes for several severe inherited diseases (21) (22) (23) (24) .
We have discussed the clinical features of the IOSCA syndrome and compared them with those in other inherited ataxias in detail elsewhere (2) . Although the peripheral neuropathy is very similar in the IOSCA and FA syndromes (3), the myocardial damage, typical of the FA syndrome, is not found in the IOSCA patients. The noncerebellar symptoms of the IOSCA syndromeathetosis, ophthalmoplegia, and deafness-are uncommon in the FA syndrome but common in autosomal dominant cerebellar ataxias. Progressive cerebellar atrophy is another common feature of the IOSCA syndrome and most subgroups of the autosomal dominant cerebellar ataxia syndromes, but the mode of inheritance and the age of onset are different. The AVED and AT syndromes do share clinical features with the IOSCA syndrome, but the serum concentrations of vitamin E, a-fetoprotein, and IgA are normal in IOSCA patients. The loss of deep tendon reflexes and the lack of spasticity differentiate the IOSCA syndrome from the FSP syndrome. At the present time, the 13 IOSCA families reported are all Finnish, making the IOSCA syndrome a typical representative of the Finnish disease heritage.
Simulation analysis suggests that the available family material would be sufficient to reveal the defective gene locus in linkage analysis. Furthermore, it is very probable in a genetic isolate that the increased frequency of some rare disease can be explained by the enrichment of a certain disease-causing allele originating from one common ancestor (founder). Consequently, if a marker is close enough to the disease gene, no recombinations, or only a small number, have occurred between the two loci in the progeny of the founder. In such cases, most of the disease carriers should have the same marker allele in the chromosome containing the disease allele; the two loci are in linkage disequilibrium (23) . Thus, in the Finnish population, linkage disequilibrium extending relatively far from the disease locus may be expected, which dramatically increases the informativeness of linkage analyses (24, 25) .
The advantage of linkage disequilibrium in linkage analysis is 2-fold: 1 ) not only can recombinations directly deducible in the families under analysis be included, but so can those occurring in their ancestors; 2) families with a single affected child, relatively uninformative in normal recombinational mapping, yield virtually the same information as those with multiple affected children. The ability to extend recombinational mapping to a larger number of families is particularly important in rare recessive disorders such as the IOSCA syndrome.
Our results show that, in addition to the specific clinical features of the IOSCA syndrome, this disease most likely also represents a genetically distinct ataxia syndrome. The random mapping procedure, aiming to assign the location of the gene for the disease, is in progress. Characterization of the IOSCA gene defect is necessary for the development of a clinical diagnosis and genetic counseling of families with an affected child. Eventually, the discovery of the molecular pathogenesis of the 10-SCA syndrome will offer new understanding of the molecules essential for the normal function of the CNS.
